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1. Introduction 
The central nervous system of the fruit fly 
Drosophila mclanogastcr has been shown [l--6] to be 
a rich source of an a-bungarotoxin-binding compo- 
nent with the properties expected of a nicotinic 
acetylcholine receptor. In view of the present confu- 
sion over the relation of a-bungarotoxin-binding 
activity to the nicotinic acetylcholine receptor in the 
vertebrate central nervous system [7,8], it is impor- 
tant to note that oc-bungarotoxin blocks synaptic 
transmission in the insect central nervous system and 
thus appears to be binding to a functional acetyl- 
choline receptor. This blockade has been demonstrated 
in the cereal nerve, giant fiber synapses in the terminal 
abdominal ganglion of the cockroach Periplatwta 
americana when the desheathed ganglion is bath- 
perfused with 1 Ow6 M toxin. Resting potentials and 
action potentials recorded within the ganglion are 
unchanged after complete blockade of synaptic 
transmission (D. B. Sattelle, B. Hue, I. D. Harrow, 
J. I. Gepner and L. M. H., unpublished observations). 
The primary motivation for extending a-bungarotoxin 
binding studies to Drosophila is to open the possibility 
of isolating mutants with altered receptors that can 
be used in the analysis of receptor structure, function 
and role in behavior and development. 
We describe here an experimental strategy for the 
detection of genetic variants that affect acetylcholine 
receptor structure. As a first step we have screened 
for nicotine-resistant flies in order to enrich for 
genetic variants affecting receptor structure. Nicotine, 
one of the oldest insecticides [9], is very effective for 
killing Drosophila, presumably because of its inter- 
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action with the acetylcholine receptor. Binding studies 
[2,3.5,6] have shown that of all the cholinergic 
ligands tested, nicotine is the best inhibitor of 
“‘l-labeled a-bungarotoxin binding to Drosophila 
extracts indicating that nicotine itself has a high 
affinity for the acetylcholine receptor. Once nicotine- 
resistant strains have been identified, isoelectric 
focusing of the acetylcholine receptor-‘2”1-labeled 
ol-bungarotoxin complex was used to distinguish 
mutants that affect receptor structure from those 
which are resistant due to other mechanisms such as 
alterations in nicotine metabolism, changes in gut or 
neural sheath permeability, or even alterations in the 
membrane environment surrounding the receptor. 
2. Materials and methods 
2.1 . Nicotirwsensitivity testitzg 
We have found that the most reprsducible way to 
administer nicotine to Drosophila is to add it as nico- 
tine hydrogen tartrate directly to the culture medium. 
Drug-containing medium was prepared by mixing 
equal volumes of Instant Drosophila Medium (Carolina 
Biological Supply Company Formula 4-24) and a 
solution at twice the final concentration of nicotine 
hydrogen tartrate (Gallard-Schlesinger catalogue 
no. 2933 1). The nicotine-containing solutions were 
all adjusted to pH 7.0, with NaOH before adding the 
Instant Medium. Eggs were collected from overnight 
egg lays. counted, and transferred to nicotine-con- 
taining medium. Cultures were grown at 25°C and 
the number of hatching adults were counted to 
determine % survival. Nicotine hydrogen tartrate in 
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the medium at 3 mM was used for routine screening electric focusing procedure was adapted from [ lo]. The 
for nicotine-resistant strains, monoiodo+bungarotoxin was prepared as in [2,11]. 
Extracts were prepared by homogenizing heads 
(40 mg heads in 4 ml) in homogenization medium 
(5 mM sodium phosphate buffer (pH 7.3), 1% (w/v) 
sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM phenyl- 
methylsulfonyl~uo~de, 1 ng/ml pepstatin, and 
20 KIU aprotinin). The homogenate was centrifuged 
at 2000 X g for 10 min and the supernatant was 
collected. The pellet was washed twice by resuspend- 
ing it in homogenization medium and centrifuging. 
The combined supernatants were filtered through 
nylon mesh and centrifuged for 30 min at 20 000 X g. 
The pellet was resuspended in 1 ml extraction medium 
(5 mM sodium phosphate buffer (pH 7.3), 500 mM 
sodium chloride, 0.1 mM phenylmethylsulfonyl- 
fluoride, 0.1 /&ml pepstatin, and 20 KIU aprotinin). 
Triton X-100 was added to final cont. 1% and the 
mixture was homogenized and incL~bated in the dark 
for 1 hat 0°C. Insoluble debris was removed by centri- 
fuging at 30 000 X g for 2 h. The supernatant was 
desalted through a Sephadex G-50 column 
(15 X 1 cm) eluted with extraction medium containing 
1% Triton X-100 and lacking NaCl. This solubilized 
extract was incubated with ~lono-12sI-Iabeled 
cr-bungarotoxin for 30 min at 22’C and then 2 vol. 
extract were mixed with 1 vol. sample buffer (4% 
LKB ampholytes, pH 5 -8, 10% sucrose, 2.5% Triton 
X-l 00,0.005% Evan’s blue dye). Samples of SO ~1 
were applied to gels and run for 2.5 h at 4°C. The 
gels (8 X 0.5 cm) were prepared in glass tubes and 
consisted of 2.9 1% acrylamide, 0.09% N,N’-methylene- 
bis-acrylamide, 1.5% Triton X-100, 2% LKB ampho- 
lytes pH 5-X and 7% glycerol and were polymerized 
with 0.06% ammonium persulfate. The upper 
(cathode) reservoir buffer was 0.4% ethylenediamine 
and 1.5% Triton X-100; the anode buffer was 0.2% 
sulfuric acid and 1.5% Triton X-l 00. Gels were prerun 
for 30 min after overlaying them with 50 1.t1 solution 
containing 2.5% sucrose, 4% ampholytes pH 5-8, 
and 1.5% Triton X-100, and then the samples were 
applied. At the end of the sample run, gels were 
frozen at -75’C, removed from the tubes, and sliced 
into 1 mm slices using equally-spaced razor blades. 
Slices were placed into tubes containing 1 ml 10 mM 
NaCl and were counted in a gamma counter. This iso- 
3. Results and discusion 
The sensitivity of the Canton-S wild-type strain to 
nicotine hydrogen tartrate in the medium is illustrated 
by the open circles in fig.1. The drug at 3 mM is 
sufficient to kill 96% of the Canton-S strain. We have 
used this concentration to screen for nicotine-resistant 
strains in wild-type populations and to date have 
identified 8 strains that are resistant to nicotine. The 
dose response curve for one of our confirmed nicotine 
resistant strains is shown in fig. 1. This strain has been 
designated HR and was isolated from the Hikone-R 
wild-type stock (obtained from the Bowling Green 
Stock Center). Half of the resistant HR strain survives 
at 3 mM nicotine hydrogen tartrate which kills 96% 
of the Canton-S strain. 
Selection for nicotine-resistantstrains provides a way 
to enrich for mutations which affect the nicotinic 
acetylcholine receptor structure, but not all nicotine- 
resistant mutants are expected to have altered receptors. 
In order to identify those resistant strains with 
altered receptors, we developed the procedure 
described in section 2 for solub~izing the receptor 
and then subjecting the receptor-1251-labeled 
a-bungarotoxin complex to isoelectric focusing. 
L I I I I 
2 4 6 8 
Concentrolton of Nicotine Hydrogen Tartrafe fm Ml 
F&.1. Comparison of sensitivity to nicotine hydrogen tartrate 
of the Canton-S (o-o) and the nicotine-resistant HR (0-o) 
strains of Drosophila melanogaster. Medium containing 
nicotine hydrogen tartratc was prepared as described in sec- 
tion 2. 200 individuals were tested for each point shown. 
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Fig.2. Isoelectric focusing of the acetylcholine receptor- 
a-bungarotoxin complex from wild-type Canton-S and nico- 
tine resistantHR strains ofDrosophila. Extracts were prepared 
and run on isoelectric focusing gels as described in section 2. 
(A) Canton-S strain alone;(B) nicotine-resistant HR strain 
alone;(C) mixture of extracts of Canton-S and HR strains. 
As shown in fig.2A, the receptor-toxin complex in 
extracts from the Canton-S strain reproducibly focused 
as a single peak with an isoelectric point of 6.60. The 
receptor-toxin complex from the nicotine-resistant 
HR strain also focused as a single peak but, as shown 
in fig.2B, its isoelectric point was shifted to pH 6.69. 
In order to demonstrate that this difference in iso- 
electric point was not due to variation between gels, 
we prepared a mixture of extracts from the two strains 
and ran them together on the same gel after pre- 
incubating them with ‘2sI-labeled cr-bungarotoxin. 
As shown in fig.2C, there were two easily distinguishable 
peaks: one with p1 6.60 corresponding to the Canton-S 
receptor-toxin complex and one with pI 6.72 corre- 
sponding to the HR receptor-toxin complex. Thus, 
we have used the isoelectric focusing procedure to 
identify ahereditary alteration in acetylcholine recep- 
tor structure. 
We have used this isoelectric focusing procedure to 
analyze the other 7 nicotine-resistant strains. Of these 
7, 5 show profiles indistinguishable from Canton-S, 
either as an extract run alone or as a mixture with 
Canton-S. The remaining two stocks show shifts in 
isoelectric point relative to Canton-S. The isoelectric 
focusing point variants may represent mutations in 
the structural genes which code for the polypeptide 
subunits of the receptor. Alternatively, they may be 
mutations in genes coding for enzymes involved in 
modification of the receptor complex. In any event, 
these mutations which we have identified to date 
cause changes in the receptor structure which do not 
drastically affect its function since all of these strains 
have apparently normal locomotor behavior. 
Both the nicotine-resistance phenotype and the 
alteration in isoelectric point of the receptor-toxin 
complex that we have observed in the HR and other 
nicotine-resistant strains could be due to alterations 
in the structure of the acetylcholine receptor. Genetic 
mapping experiments are in progress that will allow 
us to determine whether the two phenotypes are 
caused by a change in the same gene. It should be 
emphasized, however, that irrespective of whether the 
same gene is responsible for both the nicotine-resis- 
tance phenotype and the shift in isoelectric point of 
the receptor, the isoelectric focusing procedure 
presented here provides us with a direct way to iden- 
tify mutants with altered acetylcholine receptor struc- 
ture. The isoelectric focusing variants will be used to 
map genes affecting receptor structure. Knowledge of 
gene location will make it possible to design efficient 
genetic schemes for the isolation of lethal and temper- 
ature-sensitive lethal mutants which alter receptor 
structure in such a way as to render it inactive. Tem- 
perature-sensitive mutants in which the receptor is 
active at a permissive temperature and inactive at a 
nonpermissive temperature will be especially useful 
for behavioral studies and for defining the role of 
acetylcholine receptors in normal neural development. 
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